Skip to product information
1 of 1

Consumer Goods & Retailing

South America Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain M

South America Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain M

Regular price $1,188.00 USD
Regular price Sale price $1,188.00 USD
Sale Sold out
Published Date
Length Pages
SKU

South America Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
The South America transdermal medical patch market is expected to grow from US$ 343.02 million in 2023 to US$ 411.41 million by 2028. It is estimated to register a CAGR of 3.7% from 2023 to 2028.

Growing Consumption of Tobacco Fuels South America Transdermal Medical Patch Market

Nicotine replacement therapy (NRT) has proven to help people seeking to quit smoking. It makes use of nicotine patches that deliver modest nicotine dosages to relieve cravings. Nicotine is progressively absorbed through the skin once nicotine patches are applied. Smokers with a greater dependence level can use the most robust patches, while those with a lower dependence level can use a lesser dosage. The critical advantage of nicotine patches over acute NRT formulations (gum, nasal spray, oral inhaler, and tablet) is the simplicity of compliance, rather than consuming a medicine throughout the day.

Thus, the increasing consumption of tobacco leads to increasing demand for nicotine patches, thereby driving the growth of the transdermal medical patch market.

South America Transdermal Medical Patch Market Overview

The transdermal medical patch market in South America is segmented into Brazil, Argentina, and the Rest of South America. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. The market in the region is expected to grow in the coming years due to the increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies, increasing incidences of chronic diseases, and a rising geriatric population.

South America Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

South America Transdermal Medical Patch Market Segmentation

The South America transdermal medical patch market is segmented into type, application, distribution channel, and country.

Based on type, the South America transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share of the South America transdermal medical patch market in 2023.

Based on application, the South America transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.

Based on distribution channel, the South America transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the South America transdermal medical patch market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market share in 2023.

Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America transdermal medical patch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South America transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South America market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

View full details